Equity Research, Broker Reports, and media content on ESPERITE

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ESPERITE
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ESPERITE. We currently have 0 research reports from 0 professional analysts.

Open
0.90
Volume
0.2m
Range
0.80/0.90
Market Cap
8,317,087m
52 Week
0.80/2.30
Date Source Announcement
23May17 06:17 GNW ESPERITE (ESP) financial results for 2016 published
20May17 17:28 GNW Esperite further delays publication of 2016 Annual Report
19May17 12:20 GNW Esperite (ESP) announces that Genoma SA filed appeal to the decision ruled by the Swiss Court
15May17 09:17 GNW Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
15May17 06:17 GNW Esperite (ESP) - Esperite confirms the positive development of its current and future genetic activities and announces its intentions to claim 5.2 Million euro damages against Premaitha (NIPT)
11May17 08:27 GNW Esperite (ESP): Patent granted in China for treatment of acute and chronic inflammatory and autoimmune diseases with EVs technology
05May17 08:08 GNW Esperite (ESP), The Cell Factory demonstrate anti-inflammatory mode of action of CF-MEV-117 extracellular vesicle drug candidate for Epilepsy
  • Frequency of research reports

     

  • Research reports on

    ESPERITE

  • Providers covering

    ESPERITE